The story of Viagra and the medicinal industry presents a challenging picture for potential investors. Initially, copyright's hugely successful drug altered the treatment of erectile dysfunction, producing substantial profits and defining the contemporary pharmaceutical landscape. However, intellectual property expiration and the rise of off-brand